Dr. Knobe has dedicated her career to developing and delivering life-saving medicines for the rare few. She is a trained pediatric hematologist with experience in clinical practice, academia and industry. At Sanofi, she leads global development efforts to bring innovative therapies to patients with rare diseases. Her experience includes all stages of clinical development. Dr. Knobe is an MD, PhD and still holds an associate professorship at Lund University in Sweden
In light of the latest developments and as a precautionary measure, the Cyprus Presidency of the Council of the EU 2026 has decided to postpone this week’s Presidency Conference Advancement of Treatments for Rare Diseases, scheduled to take place in Cyprus 5–6 March 2026.
Further information regarding possible re-arrangement and new dates will be communicated in due course.
We apologise for the inconvenience caused by these adjustments and thank you for your understanding.
Yours sincerely,
The Organizing Committee
Conference “Advancement of Treatments for Rare Diseases”
Cyprus Presidency of the Council of the European Union 2026